Pharmacogenomics Journal

Papers
(The H4-Index of Pharmacogenomics Journal is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Cyrius: accurate CYP2D6 genotyping using whole-genome sequencing data49
Pharmacogenomics and COVID-19: clinical implications of human genome interactions with repurposed drugs31
The genetic landscape of major drug metabolizing cytochrome P450 genes—an updated analysis of population-scale sequencing data29
Economic evaluation in psychiatric pharmacogenomics: a systematic review29
Pediatric pharmacogenomics: challenges and opportunities: on behalf of the Sanford Children’s Genomic Medicine Consortium23
A systematic review and meta-analysis of genotype-based and individualized data analysis of SLCO1B1 gene and statin-induced myopathy22
Pharmacogenomics cascade testing (PhaCT): a novel approach for preemptive pharmacogenomics testing to optimize medication therapy18
Impact of CYP2C19 metaboliser status on SSRI response: a retrospective study of 9500 participants of the Australian Genetics of Depression Study17
Application of long-read sequencing to elucidate complex pharmacogenomic regions: a proof of principle16
Antihypertensive treatment guided by genetics: PEARL-HT, the randomized proof-of-concept trial comparing rostafuroxin with losartan15
Does the RAAS play a role in loss of taste and smell during COVID-19 infections?15
Spectrum of cutaneous adverse reactions to aromatic antiepileptic drugs and human leukocyte antigen genotypes in Thai patients and meta-analysis15
Side effect prediction based on drug-induced gene expression profiles and random forest with iterative feature selection14
Real-world economic evaluation of prospective rapid whole-genome sequencing compared to a matched retrospective cohort of critically ill pediatric patients in the United States14
0.020258903503418